摘要
凝血因子是凝血过程中重要的辅因子。除了凝血功能,F也通过辅助活化蛋白C下调活化因子间接参与生理性抗凝旁路途径。F的这一双重作用,使得F基因缺陷可能导致出血或血栓,形成两种完全相反的表型。本文着重就F引起遗传性凝血因子缺陷症的分子发病机制及其与临床表型的关系作一综述。
出处
《国际输血及血液学杂志》
CAS
2006年第1期13-16,共4页
International Journal of Blood Transfusion and Hematology
参考文献29
-
1Christella M, Thomassen LG, Castoldi E, e* al. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool. Haematologiea, 2003,88 : 1150-1156.
-
2Duga S, Montefusco MC, Asselta R, et al. R2074C missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein. Blood, 2003, 101:173-177.
-
3Nicolaes G A, Villoutreix B O , Dahlback B. Partial glyeosylation of Ash2181 in human factor V as a cause of molecular and funetional heterogeneity. Modulation of glycosylation efficiency by mutagenesls of the eonsensussequenee for N-linked glycosylation. Biochemistry, 1999,38:13584-13591.
-
4Srivastava A, Quinn-Allen MA, Kim SW, et al, Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor V a, Biochemistry, 2001,40(28):8246-8255.
-
5Majumder R, Quinn-Allen MA, Kane WH. The phosphatidylserine binding site of the factor V a C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor X a-factor V a complex.Biochemistry, 2005,44(2) :711-718.
-
6Dahlback B. Activated protein C resistance and thrombosis:molecular mechanisms of hypercoagulable state due to F V RS06Q mutation. Semin Thromb Hemost, 1999,25 : 273-289.
-
7Mann K G, Kalafatis M, Factor V: a combination of Dr. Jekyll and Mr. Hyde. Blood,2003, 101:20-30.
-
8Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated peotien C. Nature, 1994, 369:64-67.
-
9Dahlback B. Anticoagulant factor V and thrombosis risk. Blood,2004,103(11) :3995-3995.
-
10Nicolaes GA. Dahlback B. Factor V and Thrombotic Disease Deacription of a Janus-Faced Protein Arterioscler. Thromb Vasc Biol,2002,22:530-538.
二级参考文献19
-
1Jenny RJ, Pittman DD, Toole JJ. et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A,1987,4:4846-4850.
-
2van Wijk R, Nieuwenhuis K, van den Berg M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood,2001,98:358-367.
-
3Guasch JF, Cannegieter S, Reitsma PH. et al. Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene. Br J Haematol,1998,101:32-39.
-
4Guasch JF, Lensen RP, Bertina RM.Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Thromb Haemost,1997,77:252-257.
-
5Murray JM, Rand MD, Egan JO. et al. Factor V New Brunswick: Ala221-to-Val substitution results in reduced cofactor activity.Blood,1995,86:1820-1827.
-
6Castoldi E, Kalafatis M, Lunghi B. et al. Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thromb Haemost,1998,80:403-406.
-
7Mirochnik O, Halim-Kertanegara N, Henniker AJ, et al. A novel factor V null mutation at Arg 506 causes a false positive factor V Leiden result. Thromb Haemost,1999,82:1198-1199.
-
8Zehnder JL, Hiraki DD, Jones CD, et al. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Thromb Haemost,1999,82:1097-1099.
-
9Castoldi E, Simioni P, Kalafatis M, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood, 2000,96:1443-1448.
-
10Montefusco MC, Duga S, Asselta R, et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol,2000,111:1240-1246.
共引文献15
-
1白燕,金润铭.遗传性凝血因子缺乏症的基因缺陷和产前诊断[J].中国实用儿科杂志,2005,20(1):2-5. 被引量:2
-
2郑卫东,刘艳辉,刘辉芳,陈志红,王嬿.一个遗传性凝血因子Ⅴ缺乏症家系中凝血因子Ⅴ基因两种新突变的鉴定[J].中华医学遗传学杂志,2006,23(5):515-518. 被引量:4
-
3王静,李稻,戴菁,陆晔玲,丁秋兰,傅启华,王学锋,沈立松,王鸿利.遗传性凝血因子V缺陷症的诊断[J].检验医学,2008,23(6):600-603.
-
4周丽霞,肖勇,杨耀东.聚合酶链反应-直接测序法检测凝血因子ⅴ基因突变[J].江西农业学报,2014,26(4):100-101.
-
5侯丽虹,杨林花,刘秀娥,谢飞.遗传性因子V缺乏症的基因研究[J].山西临床医药,2002,11(4):243-245.
-
6张冬雷,薛峰,窦雪晴,刘晓帆,付荣凤,陈云飞,刘葳,贾玉娇,王玉华,肖志坚,张磊,杨仁池.遗传性凝血因子Ⅴ缺乏症九例基因分析[J].中华血液学杂志,2021,42(4):302-307. 被引量:3
-
7李可可,肖扬.凝血因子Ⅴ与出血和血栓的相关性研究进展[J].检验医学,2022,37(4):396-399. 被引量:2
-
8侯丽虹,杨林花,刘秀娥,谢飞.遗传性凝血因子Ⅴ缺乏症家系的临床研究[J].中华内科杂志,2002,41(12):836-837.
-
9秦朗译,陈怡,侯玲玲,金艳慧,芦一凡,张柯,王明山.一个遗传性凝血因子Ⅴ缺陷症家系的分子致病机制研究[J].中华血液学杂志,2024,45(12):1119-1124.
-
10傅卫军,侯健.先天性凝血因子V缺陷症的分子发病机制[J].国外医学(输血及血液学分册),2003,26(1):14-16. 被引量:1
同被引文献45
-
1郑卫东,刘艳辉,刘辉芳,陈志红,王嬿.一个遗传性凝血因子Ⅴ缺乏症家系中凝血因子Ⅴ基因两种新突变的鉴定[J].中华医学遗传学杂志,2006,23(5):515-518. 被引量:4
-
2赵冠人,冯端浩,袁伯俊.重组巴曲酶对凝血系统的双向作用[J].解放军药学学报,2006,22(5):361-365. 被引量:4
-
3许志杰,熊国祚,杨文军.食管贲门黏膜撕裂综合征误诊12例分析[J].消化外科,2006,5(6):458-458. 被引量:1
-
4于进超,祁吉.突发性耳聋的病因学及MR研究现状[J].国外医学(临床放射学分册),2007,30(3):167-170. 被引量:14
-
5ASSELTA R,TENCHINI M L,DUGA S.Inherited defects of coagulation factor V:the hemorrhagic side[J].Thromb Haemost,2006,4:26-34.
-
6MANN K G,KALAFATIS M.Factor Ⅴ:a combination of Dr.Jekyll and Mr.Hyde[J].Blood,2003,101:20-30.
-
7SORIA J M,BLANGERO J,SOUTO J C,et al.Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties[J].Human Genetics,2002,111:59-65.
-
8HUANG J N,KOERPER M A.Factor Ⅴ deficiency:a concise review[J].Haemophilia,2008,14:1164-1169.
-
9YAMAZAKI T,NICOLAES G A,SRENSEN K W,et al.Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype[J].Blood,2002,100:2515-2521.
-
10STEFANO D,ROSANNA A,MARIA L T,et al.Molecules in focus Coagulation factor Ⅴ[J].IJBCB,2004,36:1393-1399.
引证文献7
-
1程晓丽,杨婷,杨柳,辛毅娟,何睦,朱琳,刘家云.F5基因复合杂合变异导致遗传性凝血因子Ⅴ缺陷症的家系分析[J].中华医学杂志,2023,103(17):1323-1327. 被引量:1
-
2牛真珍,王明山,谢耀盛,谢海啸.一个遗传性凝血因子Ⅴ缺陷症家系的基因分析[J].临床血液学杂志,2010,23(6):654-657. 被引量:1
-
3杜长宝,杨婷,祝进,杨丽红,程晓丽,王明山.一个遗传性凝血因子Ⅴ缺陷症家系表型与基因分析[J].中国卫生检验杂志,2018,28(23):2863-2866.
-
4张运,詹晓东.突发性聋与凝血成分及凝血成分基因多态性的关系[J].中国耳鼻咽喉头颈外科,2016,23(2):84-87. 被引量:4
-
5魏蓉娜,崔莉红,李彦弢,林小林,严梓昕.食管贲门黏膜撕裂合并血友病死亡一例[J].中华胃肠外科杂志,2016,19(7):825-826. 被引量:1
-
6蔡朝阳,江天.突发性耳聋的基因学研究进展[J].浙江临床医学,2018,20(7):1312-1314. 被引量:6
-
7王佰言,张磊,王琰,雷娜,韩梅宁,张正良,张鹏宇,刘捷.获得性凝血因子Ⅴ缺乏合并血小板功能障碍的病例研究并文献复习[J].血栓与止血学,2023,29(1):37-40. 被引量:1
二级引证文献14
-
1王任炜,胡革,吴文科,常卫,蒋曼.耳聪丸治疗突发性耳聋临床疗效回顾性分析[J].亚太传统医药,2021,17(5):62-64.
-
2叶佳佳,牛真珍,马建波,陈筑.1个遗传性凝血因子Ⅴ缺陷症家系表型与基因分析[J].临床血液学杂志,2013,26(6):776-779. 被引量:1
-
3刘俞.不伴有眩晕症状突发性聋病人前庭功能评价[J].青岛大学学报(医学版),2018,54(5):584-587. 被引量:1
-
4陈鹏,罗家胜,高卓平,段学军,朱国霞,刘军.耳后骨膜下注射甲基强的松龙与静脉注射地塞米松治疗突发性耳聋的效果[J].临床医学研究与实践,2019,4(21):59-61. 被引量:11
-
5占炜.糖皮质激素联合利多卡因治疗对突发性耳聋患者sVCAM-1水平的影响[J].中国处方药,2020,18(8):134-136. 被引量:5
-
6路瑶,王彦之.突发性耳聋的针灸治疗进展[J].江苏中医药,2020,52(9):86-89. 被引量:5
-
7燕爱凤,徐英,李桂芹.突发性感音神经性聋和铁稳态基因多态性的相关性研究[J].临床和实验医学杂志,2020,19(17):1838-1841. 被引量:1
-
8唐一萍,冯俊,马鹏,罗德艳.miRNA-183在噪声性耳聋大鼠耳蜗组织中的表达及临床意义[J].陕西医学杂志,2021,50(5):538-541. 被引量:5
-
9陈天杰,王瑞霞,赵淑磊.贲门撕裂合并轻型血友病1例[J].山东第一医科大学(山东省医学科学院)学报,2023,44(4):298-299. 被引量:1
-
10王世馨,于亚峰.血脂水平与突发性耳聋患者临床特性的相关性分析[J].浙江临床医学,2023,25(4):551-553. 被引量:1
-
1赵晓燕,苏金林,张兴凯.糜酶与心血管疾病间关系的研究进展[J].宁夏医学杂志,2010,32(1):91-92. 被引量:4
-
2俞秋霞,张慧娟,郝菲,白盟盟.新的脂肪细胞因子与糖尿病肾病[J].国际内分泌代谢杂志,2012,32(5):344-347. 被引量:2
-
3郭建新,王东明,黄红梅,杨燕雯,常项海.31例类风湿关节炎患者血清白细胞介素-6的水平分析[J].中国全科医学,2003,6(10):832-832.
-
4赵元明,刘凌云,董海新,苏昕,于瑞雪.糖尿病患者血清脂质、胰岛素、性激素的变化及其相互关系的探讨[J].医学检验与临床,2003,15(1):32-33.
-
5张帆,李芹.糖尿病患者血脂与血糖水平变化相互关系的探讨[J].中国社区医师(医学专业),2005,7(12):87-88. 被引量:3
-
6沈迪,吴洁.高尿酸血症与部分动脉粥样硬化危险因素的关系[J].中南医学科学杂志,2016,44(5):591-593. 被引量:4
-
7刘立根,傅启华,王鸿利,周荣富,王文斌,丁秋兰,武文漫,胡翊群,王学锋,王振义.遗传性凝血因子V缺陷症的实验室诊断[J].中华检验医学杂志,2004,27(2):93-96. 被引量:3
-
8牛真珍,王明山,谢耀盛,谢海啸.一个遗传性凝血因子Ⅴ缺陷症家系的基因分析[J].临床血液学杂志,2010,23(6):654-657. 被引量:1
-
9王静,李稻,戴菁,陆晔玲,丁秋兰,傅启华,王学锋,沈立松,王鸿利.遗传性凝血因子V缺陷症的诊断[J].检验医学,2008,23(6):600-603.
-
10叶佳佳,牛真珍,马建波,陈筑.1个遗传性凝血因子Ⅴ缺陷症家系表型与基因分析[J].临床血液学杂志,2013,26(6):776-779. 被引量:1